End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.6 CNY | -1.38% | +1.30% | -45.57% |
05-16 | Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials | MT |
04-25 | Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Chengdu Olymvax Biopharmaceuticals Inc.
Upcoming events on Chengdu Olymvax Biopharmaceuticals Inc.
Past events on Chengdu Olymvax Biopharmaceuticals Inc.
2024-04-25 | Q4 2023 Earnings Release |
2024-04-24 | Q1 2024 Earnings Release |
2023-10-26 | Q3 2023 Earnings Release |
2023-08-17 | Q2 2023 Earnings Release |
2023-04-25 | Q4 2022 Earnings Release |
2023-04-25 | Q1 2023 Earnings Release |
2022-10-28 | Q3 2022 Earnings Release |
2022-08-17 | Interim 2022 Earnings Release |
2022-04-27 | Q1 2022 Earnings Release |
2022-04-27 | FY 2021 Earnings Release |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 320 | 487 513 -5.04% | 547 595 -7.99% | 496 633 -21.59% | 658 |
EBITDA Million CNY | Released Forecast Spread | 0,00 | 126 132 -4.35% | 70,3 87,0 -19.15% | 33,4 105 -68.22% | 120 |
EBIT Million CNY | Released Forecast Spread | 0,00 | 102 124 -18.08% | 41,6 64,0 -34.97% | 3,40 69,6 -95.11% | 59,0 |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 | 107 124 -13.56% | 43,6 64,0 -31.8% | 15,9 71,9 -77.87% | 66,0 |
Net income Million CNY | Released Forecast Spread | 36,9 | 108 124 -12.93% | 26,6 64,0 -58.47% | 17,4 61,3 -71.58% | 79,0 |
EPS CNY | Released Forecast Spread | 0,00 | 0,28 0,31 -9.55% | 0,07 0,14 -53.14% | 0,04 0,15 -70.92% | 0,19 |
Announcement Date | 18/05/21 | 22/02/22 | 27/02/23 | 27/02/24 | - |
2024-07-11 02:00 | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
2024-07-15 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
2024-07-22 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 02:00 | BIOGAIA AB: Q2 2024 Earnings Release |
2024-07-23 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
2024-07-25 01:00 | UCB: Q2 2024 Earnings Release |
2024-07-25 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
2024-07-29 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Chengdu Olymvax Biopharmaceuticals Inc.
2024-05-14 11:35 | GRIFOLS, S.A.: Q1 2024 Earnings Release |
2024-05-12 | ALTEOGEN INC.: Q1 2024 Earnings Release (Projected) |
2024-05-09 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
2024-05-09 | MEDY-TOX INC.: Q1 2024 Earnings Release |
2024-05-09 16:05 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
2024-05-09 16:05 | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
2024-05-09 02:30 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
2024-05-08 | HUGEL, INC.: Q1 2024 Earnings Release |
2024-05-08 16:16 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-08 16:05 | ZAI LAB LIMITED: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688319 Stock
- Calendar Chengdu Olymvax Biopharmaceuticals Inc.